Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -1039.56% is 900% below its 5-year average of -103.96%, near the low end of its 5-year range (-1039.56%–-53.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 225.45% below its 12-month average of -319.42%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -1039.56%.
RETURN ON INVESTED CAPITAL (ROIC)
-1039.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-319.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-133.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-103.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-92.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-225.45%
CURRENT VS 3Y AVG
-681.46%
CURRENT VS 5Y AVG
-899.95%
CURRENT VS 10Y AVG
-1027.89%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 614 covered companies
CURRENT VS SECTOR MEDIAN
-3013.86%
vs the sector median at left
Cue Biopharma, Inc.
Market Cap
$173.89M
Return on Invested Capital (ROIC)
-1039.56%
TTM Avg
-319.42%
3Y Avg
-133.03%
5Y Avg
-103.96%
Market Cap
$172.77M
Return on Invested Capital (ROIC)
-58.55%
TTM Avg
-41.33%
3Y Avg
-32.67%
5Y Avg
-48.97%
Market Cap
$172.18M
Return on Invested Capital (ROIC)
-30.23%
TTM Avg
-28.70%
3Y Avg
-31.34%
5Y Avg
-41.69%
Market Cap
$172.07M
Return on Invested Capital (ROIC)
-42.11%
TTM Avg
-29.16%
3Y Avg
-30.37%
5Y Avg
-28.38%
Market Cap
$177.78M
Return on Invested Capital (ROIC)
-46.59%
TTM Avg
-39.23%
3Y Avg
-33.74%
5Y Avg
-53.74%
Market Cap
$169.41M
Return on Invested Capital (ROIC)
4.92%
TTM Avg
-1.65%
3Y Avg
-7.20%
5Y Avg
-5.46%
Market Cap
$179.09M
Return on Invested Capital (ROIC)
-5.22%
TTM Avg
-22.12%
3Y Avg
-29.09%
5Y Avg
-27.39%
Market Cap
$168.56M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
4.10%
3Y Avg
3.63%
5Y Avg
7.54%
Market Cap
$180.85M
Return on Invested Capital (ROIC)
-9.57%
TTM Avg
-477.38%
3Y Avg
-295.61%
5Y Avg
-295.61%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | $173.89M | -1039.56% | -319.42% | -133.03% | -103.96% |
| MediWound Ltd. (MDWD)vs › | $172.77M | -58.55% | -41.33% | -32.67% | -48.97% |
| Precision BioSciences, Inc. (DTIL)vs › | $172.18M | -30.23% | -28.70% | -31.34% | -41.69% |
| Nkarta, Inc. (NKTX)vs › | $172.07M | -42.11% | -29.16% | -30.37% | -28.38% |
| Compass Therapeutics, Inc. (CMPX)vs › | $177.78M | -46.59% | -39.23% | -33.74% | -53.74% |
| OptimizeRx Corp. (OPRX)vs › | $169.41M | 4.92% | -1.65% | -7.20% | -5.46% |
| Journey Medical Corporation (DERM)vs › | $179.09M | -5.22% | -22.12% | -29.09% | -27.39% |
| Organogenesis Holdings Inc. (ORGO)vs › | $168.56M | -8.34% | 4.10% | 3.63% | 7.54% |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.85M | -9.57% | -477.38% | -295.61% | -295.61% |
| Coherus Oncology, Inc. (CHRS)vs › | $165.32M | -135.38% | -110.80% | -91.23% | -65.73% |
ROIC
-1039.6%
ROE
-7104.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -1039.56% |
| 2026-03-31 | -83.39% |
| 2025-12-31 | -92.35% |
| 2025-09-30 | -216.81% |
| 2025-06-30 | -164.99% |
| 2025-03-31 | -406.02% |
| 2024-12-31 | -181.73% |
| 2024-09-30 | -142.88% |
| 2024-06-30 | -161.91% |
| 2024-03-31 | -129.16% |
| 2023-12-31 | -107.72% |
| 2023-09-30 | -95.58% |
| 2023-06-30 | -86.81% |
| 2023-03-31 | -73.93% |
| 2022-12-31 | -65.15% |
| 2022-09-30 | -65.72% |
| 2022-06-30 | -63.12% |
| 2022-03-31 | -53.67% |
| 2021-12-31 | -60.25% |
| 2021-09-30 | -73.70% |
| 2021-06-30 | -56.41% |
| 2021-03-31 | -57.82% |
| 2020-12-31 | -54.13% |
| 2020-09-30 | -44.43% |
| 2020-06-30 | -44.13% |
| 2020-03-31 | -72.23% |
| 2019-12-31 | -61.33% |
| 2019-09-30 | -111.21% |
| 2019-06-30 | -145.58% |
| 2019-03-31 | -123.14% |
| 2018-12-31 | -98.91% |
| 2018-09-30 | -95.49% |
| 2018-06-30 | -60.75% |
| 2018-03-31 | -47.62% |
| 2017-12-31 | -37.71% |
| 2017-09-30 | -356.96% |
| 2017-06-30 | -145.81% |
| 2016-12-31 | -50.35% |
